Stocks in Play: Crescita Therapeutics Inc.
Wednesday, May 14, 202510:09 AM EST - Crescita Therapeutics Inc. : Today reported its financial results for the first quarter ended March 31, 2025. Revenue was $3,537, compared to $4,996, a decrease of $1,459. Gross profit was $1,747, compared to $2,411, a decrease of $664. Operating expenses were $2,809, compared to $3,142, a decrease of $333. Net loss was $(932), compared to $(626), an increase of $306. Crescita Therapeutics Inc. (T.CTX) shares were down $0.01 at 0.52.Stocks in Play: Crescita Therapeutics Inc., Thu, 15 May 2025 03:42:05 EST
Recent Posts
Europe Faces Most Difficult Moment in Bid to Avoid Split With US
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
Hastings Racecourse in Vancouver to shut down permanently, operator says
Russia’s Vital Oil Trade With India Is Down, But Not Out
Copper Quest Closes $1,927,000 Private Placement
This TSX stock was up 17% this week and it could gain another 36%, analysts say
AMC Entertainment Holdings, Inc. Transfers the Majority of its Equity Investment in Hycroft Mining Holding Corporation to Sprott Mining for a Net Consideration of $24.1 million
Guardian Capital Announces Estimated 2025 Annual Non-Cash Distributions for Guardian Capital ETFs
Emera Renews At-The-Market Equity Program
CRA warns of ‘aggressive tax schemes’ involving critical illness insurance
